Pharmacology - Immunopharmacology (Exam 5) Flashcards

(47 cards)

1
Q

3 features of modulation

A
  1. Induction
  2. Enhancement
  3. Suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 main components of the immune system

A
  1. Cells
  2. Immune mediators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 2 immune mediators

A
  1. Cytokines
  2. Humoral antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the basics of the immune system

A

Immune system is split into innate and adaptive immunity:

Innate = physical barriers + blood-borne

Adaptive (think specific!!) = B cells (humoral) + T cells (cell-mediated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Purpose of physical barriers

A

Stops entry of pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Purpose of B cells

A

Make antibodies that activate the complement cascade

(which in turn will activate an alternative pathway and activate innate immunity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Function of T cells

A

Death of damaged or infected body cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F innate and adaptive immunity work together

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Activation of __________ is the necessary first step for the induction of adaptive immunity

A

APCs = monocytes, B cells, and DC’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

First encounter of a naive T cell w/ the antigen on a mature dendritic cell

A

Priming

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

B cell receptors are more specific. Why?

A

They can recognize secondary, tertiary, and quaternary structural features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Differences b/w MHC I and MHC II

A

MHC I = deliver peptides originating from cytosol

MHC II = deliver peptides from vesicular compartments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MHC I activates _____ cells while MHC II activates ______ cells

A

I - CD8 cytotoxic
II - CD4 helper and B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The variable region of Ig is called the?

A

Antibody segment - Fab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The six hypervariable regions in each arm of the antibody are ___________ to the antigen

A

Complementary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Predominant cells in acute inflammation

A

Neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Immune responses are usually initiated by an immediate inflammatory reaction resulting from the activation of ____________ factors

A

Soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When helper T cells are activated, they have 2 actions. What are they?

A
  1. activate cytokines
  2. activate B cells to make antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

An antigen receptor formed is rigorously tested against?

A

Self-peptides

20
Q

Two methods that effector cells use to kill targets

A
  1. apoptosis - caspases
  2. cytolysis - granzymes
21
Q

These cells mediate direct cytotoxicity and antibody-dependent cellular cytotoxicity

22
Q

When NK cells interact with tumor cells, they lose cytotoxicity but gain the ability to secrete cytokines, a concept that has been coined

23
Q

2 methods to terminate immune responses

A
  1. propiocidal apoptosis
  2. immune regulation & suppression
24
Q

The largest and most important part of the immune system

A

mucosal immune system

25
Name 3 cells found throughout the mucosa
1. lymphocytes 2. macrophages 3. dendritic cells
26
The mucosal antibody
IgA!!
27
donor was immunized with an antigen, and a recipient host was then injected with the protective antibodies generated by the donor
passive immunization
28
The suffix of the monoclonal antibody tells us the % of human. (KNOW THIS) -omab -ximab -zumab -umab
omab = 0% ximab = 65% zumab = >90% umab = 100%
29
Examples of immunophilin ligands (3)
1. Cyclosporine 2. Tacrolimus 3. Sirolimus
30
MOA of immunophilin ligands
Bind Cyclophines
31
Thalidomide and lenalidomide have powerful ____________ effects
teratogenic
32
MOA of cytotoxic drugs
Kill lymphocytes Interfere w/ proliferative stage of immune response
33
Interleukins can treat
hematopoietic deficiencies
34
Interleukins can treat __________ at high doses, but they treat ___________ at low doses
cancer; autoimmune diseases
35
Difference b/w TH1 and TH2 cytokines
TH1 - cytosolic TH2 - extracellular
36
When dendritic cell encounters cancer, it activates?
T helper cell or cytotoxic
37
Tumors promote the expansion of suppressor cells like
Treg and myeloid-derived suppressor cells
38
Tumor cells can express ________ which binds to ________ on T effector cells to induce exhaustion
PD-L1; PD-1
39
4 main immunotherapies for cancer treatment
1. T cell receptors 2. chimeric antigen receptor 3. tumor infiltrating lymphocytes 4. NK cells
40
T/F: Triazoles are more selective for fungal cyt P450 than imidazoles
True
41
How does a tumor induce immunosuppression?
1. They will express suppressor cells like Treg and myeloid-derived suppressor cells 2. The tumor cells will also express PDL-1 which binds to PD-1 on the dendritic cell 3. This induces exhaustion
42
Bee venom is a good model for what kind of procedures?
Cytokine therapy It's associated w/ a TH2 -> TH1 shift and this favors IgG instead of IgE
43
How to recognize chimeric antibody
-xi root Examples: infliximab, rituximab and abciximab
44
Chimeric antibodies contain __________ constant domain and ____________ variable domains.
human; mouse
45
Antigen exposure converts B cells into
lymphoblasts
46
Chimeric antigen receptor T cells (CAR/T cells) combine both antibody like recognition site with
T-cell activating function
47
Why are NK cells expanded and delivered to patients?
Eliminate cancer stem cells and differentiation of the remaining tumors to inhibit cancer metastasis